BusinessManufacturing

Ypsomed Announces Major U.S. Expansion with $200M North Carolina Manufacturing Facility

Ypsomed is establishing its inaugural United States manufacturing presence with a strategic investment in Wake County, North Carolina. The Swiss medical device leader plans to create up to 200 jobs while enhancing supply security for the American healthcare market.

In a significant strategic move, Swiss medical technology leader Ypsomed has announced plans to establish its first manufacturing facility in the United States, marking a pivotal expansion in the company’s global growth strategy. The company will invest approximately CHF 200 million (approximately $220 million USD using current Swiss franc exchange rates) in the initial phase of development in Holly Springs, North Carolina.

Strategic Location Selection in North Carolina’s Growing Medical Hub